Universal Health Services, Inc. Announces Third Quarter 2018 Earnings Release And Conference Call
KING OF PRUSSIA, Pa., Oct. 15, 2018 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2018 after the market closes on Thursday, October 25, 2018. There will be a conference call for investors and analysts at 9:00 a.m. Eastern Time on Friday, October 26, 2018. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on the company's website at www.uhsinc.com. Also, a replay of the call will be available following the conclusion of the live call for one full year.
Universal Health Services, Inc. is one of the nation's largest hospital companies operating through its subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands.
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme").
For this purpose, Sobi has prepared a base prospectus, which...
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...
Today, RaySearch Laboratories AB (publ) publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.
This information is information that RaySearch Larboratiories AB...
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM.
The company aims to webcast the...
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website.
"Implantica had a very...
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...
